Search results
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 1 day agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3...
Equities Analysts Offer Predictions for AstraZeneca PLC’s Q2 2024 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for AstraZeneca in a report released on ...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 2 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
... Over $2B To Boost France's Healthcare Sector - AstraZeneca (NASDAQ:AZN), Pfizer (NYSE:PFE),...
Benzinga· 4 days agoPfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D...
7 Blue-Chip Stocks to Protect Your Wealth as the Economy Slows
InvestorPlace· 2 days agoFor Q1 2024, GDP growth in the United States decelerated to 1.6% from 3.4% in the last quarter. At...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 6 hours ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France By Reuters
Investing.com· 6 days agoLeading healthcare companies Pfizer (NYSE:PFE) and AstraZeneca (NASDAQ:AZN) announced on Sunday new...
Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress By Investing.com
Investing.com· 3 days agoThe biotech company, which specializes in cancer immunotherapy, emphasized advancements in its...
Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’
InvestorPlace· 7 hours agoResearchers can now use AI to find new drug candidates much faster than currently possible. The future of medicine is here.
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 5 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...